These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 34638315)

  • 21. FGFR signaling regulates resistance of head and neck cancer stem cells to cisplatin.
    McDermott SC; Rodriguez-Ramirez C; McDermott SP; Wicha MS; Nör JE
    Oncotarget; 2018 May; 9(38):25148-25165. PubMed ID: 29861860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cisplatin overcomes radiotherapy resistance in OCT4-expressing head and neck squamous cell carcinoma.
    Routila J; Qiao X; Weltner J; Rantala JK; Carpén T; Hagström J; Mäkitie A; Leivo I; Ruuskanen M; Söderlund J; Rintala M; Hietanen S; Irjala H; Minn H; Westermarck J; Ventelä S
    Oral Oncol; 2022 Apr; 127():105772. PubMed ID: 35245886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AKR1C1 controls cisplatin-resistance in head and neck squamous cell carcinoma through cross-talk with the STAT1/3 signaling pathway.
    Chang WM; Chang YC; Yang YC; Lin SK; Chang PM; Hsiao M
    J Exp Clin Cancer Res; 2019 Jun; 38(1):245. PubMed ID: 31182137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. XIAP is a predictor of cisplatin-based chemotherapy response and prognosis for patients with advanced head and neck cancer.
    Yang XH; Feng ZE; Yan M; Hanada S; Zuo H; Yang CZ; Han ZG; Guo W; Chen WT; Zhang P
    PLoS One; 2012; 7(3):e31601. PubMed ID: 22403616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer stem cell mediated acquired chemoresistance in head and neck cancer can be abrogated by aldehyde dehydrogenase 1 A1 inhibition.
    Kulsum S; Sudheendra HV; Pandian R; Ravindra DR; Siddappa G; R N; Chevour P; Ramachandran B; Sagar M; Jayaprakash A; Mehta A; Kekatpure V; Hedne N; Kuriakose MA; Suresh A
    Mol Carcinog; 2017 Feb; 56(2):694-711. PubMed ID: 27380877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiproliferative efficacies but minor drug transporter inducing effects of paclitaxel, cisplatin, or 5-fluorouracil in a murine xenograft model for head and neck squamous cell carcinoma.
    Theile D; Gal Z; Warta R; Rigalli JP; Lahrmann B; Grabe N; Herold-Mende C; Dyckhoff G; Weiss J
    Cancer Biol Ther; 2014 Apr; 15(4):436-42. PubMed ID: 24448417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cisplatin and radiation sensitivity in human head and neck squamous carcinomas are independently modulated by glutathione and transcription factor NF-kappaB.
    Kato T; Duffey DC; Ondrey FG; Dong G; Chen Z; Cook JA; Mitchell JB; Van Waes C
    Head Neck; 2000 Dec; 22(8):748-59. PubMed ID: 11084634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel CREB5/TOP1MT axis confers cisplatin resistance through inhibiting mitochondrial apoptosis in head and neck squamous cell carcinoma.
    Tong T; Qin X; Jiang Y; Guo H; Wang X; Li Y; Xie F; Lu H; Zhai P; Ma H; Zhang J
    BMC Med; 2022 Jul; 20(1):231. PubMed ID: 35773668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of cisplatin-resistant factor by integration of transcriptomic and proteomic data using head and neck carcinoma cell lines.
    Inukai D; Nishimura K; Okamoto H; Sano R; Ueda H; Ota A; Karnan S; Hosokawa Y; Yoshikawa K; Suzuki S; Ueda R; Murotani K; Bradford CR; Ogawa T
    Nagoya J Med Sci; 2020 Aug; 82(3):519-531. PubMed ID: 33132436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of cisplatin-resistant head and neck squamous cell carcinoma by the SRC/ETS-1 signaling pathway.
    Yang Z; Liao J; Carter-Cooper BA; Lapidus RG; Cullen KJ; Dan H
    BMC Cancer; 2019 May; 19(1):485. PubMed ID: 31118072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IKK phosphorylation of NF-κB at serine 536 contributes to acquired cisplatin resistance in head and neck squamous cell cancer.
    Li Z; Yang Z; Lapidus RG; Liu X; Cullen KJ; Dan HC
    Am J Cancer Res; 2015; 5(10):3098-110. PubMed ID: 26693062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. lncRNA lnc-POP1-1 upregulated by VN1R5 promotes cisplatin resistance in head and neck squamous cell carcinoma through interaction with MCM5.
    Jiang Y; Guo H; Tong T; Xie F; Qin X; Wang X; Chen W; Zhang J
    Mol Ther; 2022 Jan; 30(1):448-467. PubMed ID: 34111560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metastases of squamous cell carcinoma of the head and neck show increased levels of nucleotide excision repair protein XPF in vivo that correlate with increased chemoresistance ex vivo.
    Köberle B; Ditz C; Kausch I; Wollenberg B; Ferris RL; Albers AE
    Int J Oncol; 2010 May; 36(5):1277-84. PubMed ID: 20372803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of carbonic anhydrases IX/XII by SLC-0111 boosts cisplatin effects in hampering head and neck squamous carcinoma cell growth and invasion.
    Sarnella A; Ferrara Y; Auletta L; Albanese S; Cerchia L; Alterio V; De Simone G; Supuran CT; Zannetti A
    J Exp Clin Cancer Res; 2022 Apr; 41(1):122. PubMed ID: 35365193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Valproic Acid Synergizes With Cisplatin and Cetuximab
    Iannelli F; Zotti AI; Roca MS; Grumetti L; Lombardi R; Moccia T; Vitagliano C; Milone MR; Ciardiello C; Bruzzese F; Leone A; Cavalcanti E; De Cecio R; Iachetta G; Valiante S; Ionna F; Caponigro F; Di Gennaro E; Budillon A
    Front Cell Dev Biol; 2020; 8():732. PubMed ID: 33015030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Livin enhances chemoresistance in head and neck squamous cell carcinoma.
    Yoon TM; Kim SA; Lee DH; Lee JK; Park YL; Lee KH; Chung IJ; Joo YE; Lim SC
    Oncol Rep; 2017 Jun; 37(6):3667-3673. PubMed ID: 28440463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TRPM7 via calcineurin/NFAT pathway mediates metastasis and chemotherapeutic resistance in head and neck squamous cell carcinoma.
    Chen TM; Huang CM; Hsieh MS; Lin CS; Lee WH; Yeh CT; Liu SC
    Aging (Albany NY); 2022 Jun; 14(12):5250-5270. PubMed ID: 35771152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HPV Enhances HNSCC Chemosensitization by Inhibiting SERPINB3 Expression to Disrupt the Fanconi Anemia Pathway.
    Huang Z; Chen Y; Chen R; Zhou B; Wang Y; Hong L; Wang Y; Wang J; Xu X; Huang Z; Chen W
    Adv Sci (Weinh); 2022 Nov; 10(1):e2202437. PubMed ID: 36382555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Wee-1 Kinase Inhibition Sensitizes High-Risk HPV+ HNSCC to Apoptosis Accompanied by Downregulation of MCl-1 and XIAP Antiapoptotic Proteins.
    Tanaka N; Patel AA; Wang J; Frederick MJ; Kalu NN; Zhao M; Fitzgerald AL; Xie TX; Silver NL; Caulin C; Zhou G; Skinner HD; Johnson FM; Myers JN; Osman AA
    Clin Cancer Res; 2015 Nov; 21(21):4831-44. PubMed ID: 26124202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NFκB mediates cisplatin resistance through histone modifications in head and neck squamous cell carcinoma (HNSCC).
    Almeida LO; Abrahao AC; Rosselli-Murai LK; Giudice FS; Zagni C; Leopoldino AM; Squarize CH; Castilho RM
    FEBS Open Bio; 2014; 4():96-104. PubMed ID: 24490130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.